Use of anthrax vaccine in the United States.

  • 15 December 2000
    • journal article
    • Vol. 49, 1-20
Abstract
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

This publication has 0 references indexed in Scilit: